rcoledude

320 posts

rcoledude

rcoledude

@rcoledude

Katılım Aralık 2008
129 Takip Edilen794 Takipçiler
aka
aka@akafaceUS·
What number do you see ??
aka tweet media
English
1.4K
36
468
102.8K
rcoledude
rcoledude@rcoledude·
So excited to see the gentle giant be recognized at #SGO 2025 annual meeting for contributions to the field particularly in rare ovarian tumors. John Farley also faithfully service our country as a colonel in the US military. Congratulations John! ⁦⁦@VaniamGroup
rcoledude tweet media
English
5
5
28
2.6K
rcoledude
rcoledude@rcoledude·
Great session on PARPi in the current clinical climate. Patient-level decision algorithms will become more complicated and nuanced as Keylynk and FIRST report adding to data from DUO-O. Exciting options for patients #vaniam@ESGO_society
rcoledude tweet media
English
0
2
15
786
rcoledude
rcoledude@rcoledude·
@leitaomd Truly sad and shocking. we were just together 3 weeks ago at a recent meeting where he outlined the development of expanded molecular characterization of Gyn tumors. Always on the forefront of discovery and mentorship. He will be missed. @ESGO
English
0
1
9
413
rcoledude
rcoledude@rcoledude·
Day 1 of #ESGO2025 Program filled with updates across the Gyn oncology spectrum. Always a great networking event with friends and colleagues in practice and industry with time to discuss and debate the clinical utility of the research findings. @VaniamGroup @GOG
rcoledude tweet media
English
1
1
29
1.9K
rcoledude
rcoledude@rcoledude·
This year’s SGO Winter Meeting brought exciting new research, insightful clinical trial reviews, and nuanced treatment strategies that are reshaping how we look at patient care. Integrating tumor biology into therapeutic advancements was particularly impactful. @vaniamgroup
rcoledude tweet media
English
0
2
9
354
rcoledude
rcoledude@rcoledude·
Excited to see ROCC trial discussed at the winter SGO 2025 meeting. Thanks Dr Teoh for your discussion
rcoledude tweet media
English
1
1
13
1.5K
rcoledude
rcoledude@rcoledude·
Not my usual domain but excited to learn how novel therapies are being developed in other tumor types or under similar competitive treatment landscapes #ASH #vaniam
rcoledude tweet media
English
0
0
21
533
rcoledude
rcoledude@rcoledude·
Two major events, one big goal: transforming lives through innovation. Counting down to #ash24 #sabcs
English
0
0
3
294
rcoledude
rcoledude@rcoledude·
Celebrating Dr Ng and his tremendous work with our mentorship and training program. A huge success in bring expertise to many areas of the world with limited resources. We owe you and the team a huge debt of gratitude - thanks!
rcoledude tweet media
English
1
1
21
1.1K
rcoledude
rcoledude@rcoledude·
@AngelesSecord Legitimately drop the mic with all the music references. Loved it!
English
0
0
3
63
Angeles Secord
Angeles Secord@AngelesSecord·
Wow Drop the mic moment Dr Ramez!!!! Review of DUO-E and KN-B21
Angeles Secord tweet mediaAngeles Secord tweet mediaAngeles Secord tweet media
English
2
7
16
2.4K
rcoledude
rcoledude@rcoledude·
Congratulations Dr Cloven presenting quality of life data from the RUBY trial at #IGCS2024
rcoledude tweet mediarcoledude tweet media
English
0
4
12
725
rcoledude
rcoledude@rcoledude·
Congratulations Shannon on updated results on DUO-E at #igcs2024
rcoledude tweet media
English
0
7
29
1.6K
rcoledude
rcoledude@rcoledude·
Happy to be at #IGCS2024 but with a solemn moment to remember our dear friends and patients who we lost
rcoledude tweet media
English
0
2
37
1.4K
rcoledude
rcoledude@rcoledude·
@IGCSociety Awesome to be here! Wonderful program-congratulations to the amazing program committee and the IGCS staff for their expert management #igcs2024
English
0
0
2
111
IGCS
IGCS@IGCSociety·
✨ Tomorrow is the day! Just 1 more sleep until #IGCS2024! 📍 Get ready for an incredible gathering of experts and advocates pushing the boundaries of gynecologic cancer care. 🎉 We can't wait to see you there!
IGCS tweet media
English
1
5
24
4.1K